Anaptysbio (ANAB) EBIT Margin Growth (1y) (2017 - 2026)
Anaptysbio (ANAB) EBIT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -3,637.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,637.00 |
| Dec 31, 2025 | 12,788.00 |
| Sep 30, 2025 | 22,112.00 |
| Jun 30, 2025 | 24,997.00 |
| Mar 31, 2025 | 48,867.00 |
| Dec 31, 2024 | 42,923.00 |
| Sep 30, 2024 | 98,548.00 |
| Jun 30, 2024 | 79,268.00 |
| Mar 31, 2024 | 264,367.00 |
| Dec 31, 2023 | 5,155.00 |
| Sep 30, 2023 | 115,461.00 |
| Jun 30, 2023 | 112,590.00 |
| Mar 31, 2023 | 4,158.00 |
| Dec 31, 2022 | 256,234.00 |
| Sep 30, 2022 | -225,799.00 |
| Jun 30, 2022 | -228,344.00 |
| Mar 31, 2022 | -308,948.00 |
| Dec 31, 2021 | -313,738.00 |
| Mar 31, 2021 | 2,145.00 |
| Dec 31, 2020 | 79,751.00 |